{"id":"W2154488022","doi":"10.1158/1078-0432.ccr-10-1869","title":"Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"National Cancer Institute","keywords":"Gefitinib; Tamoxifen; Medicine; Internal medicine; Breast cancer; Placebo; Oncology; Metastatic breast cancer; Cancer; Epidermal growth factor receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002533747,0.002198459,0.004529623,0.0006802275,0.0004751457,0.001125691,0.0009334534,0.002165431,0.006928897],"category_scores_gemma":[0.002295353,0.0008693666,0.002484891,0.0005607241,0.001225383,0.001323126,0.0004384377,0.002458655,0.001143547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008859914,"about_ca_system_score_gemma":0.001192696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006491121,"about_ca_topic_score_gemma":0.001716249,"domain_scores_codex":[0.9989215,0.0006670812,0.00006388464,0.0001592276,0.00006561428,0.0001227556],"domain_scores_gemma":[0.9989088,0.000339677,0.0002802751,0.00009609378,0.00007348321,0.0003016903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9782026,0.007292854,0.0004529713,0.0005485288,0.0008253509,0.00002815458,0.00002824422,0.0002244012,0.001347393,0.00004322801,0.0003740315,0.01063222],"study_design_scores_gemma":[0.941048,0.05723578,0.0007906979,0.00001980874,0.0002881936,0.0000193272,0.000009055454,0.0001607399,0.0001060341,0.0000501817,0.0002649672,0.000007229807],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9793555,0.009312292,0.0007606397,0.0008850692,0.000850325,0.00601187,0.001028614,0.0001373201,0.001658413],"genre_scores_gemma":[0.9806958,0.005235851,0.00125587,0.001193766,0.0009462307,0.007398868,0.001037864,0.00002539909,0.002210338],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006928897,"threshold_uncertainty_score":0.02317947,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1388367152218822,"score_gpt":0.4788527990782955,"score_spread":0.3400160838564134,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}